Kevin Cooper is a Partner at Cooley, based in New York, where he specializes in Mergers and Acquisitions, Activism Defense, Private Equity, and Wellness. Kevin advises clients and their boards on complex, high-stakes M&A transactions and transformative corporate matters, particularly in the life sciences, technology, and consumer products sectors. Notable transactions include advising Neurocrine on its $2.9 billion acquisition of Soleno Therapeutics and Clorox on its $2.25 billion acquisition of GOJO. He has also represented financial advisors such as Centerview and Morgan Stanley in M&A transactions. Before joining Cooley, Kevin was part of the corporate department at a prominent New York City law firm. He holds an MBA and a bachelor's degree in finance, and he played NCAA Division I football for the Fresno State Bulldogs.
LinkedIn
